Conclusion and implications:
In
hyperuricemia-related
CKD, ITGAM promotes macrophage M2 polarization contributing to renal
fibrosis through FAK/Akt1/β-catenin signaling pathway. Targeting
macrophage ITGAM might be a promising therapeutic approach for
preventing or delaying CKD.